Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 5, 2026

On May 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at an average US$21.22 for US$573K under a trading plan, leaving 115,743 shares. Filed May 5, 2026 (Form 4).

Sold
27,000 shares
Price
US$21.22 average (US$21.19 to US$22.00)
Value
US$573K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise27,000US$5.20142,743Direct
May 1, 2026Common StockSale25,900US$21.19116,843Direct
May 1, 2026Common StockSale1,100US$22.00115,743Direct

Source

View original at SEC

Related